Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression.
Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression.
复制标题
NO、血管扩张剂前列腺素和腺苷对骨骼肌血管生成生长因子基因表达的影响。
DOI:
10.1152/jappl.1999.86.5.1513
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Wagner,PD
中科院分区:
文献类型:
--
作者:
Benoit,H;Jordan,M;Wagner,H;Wagner,PD
Exercise training results in several muscle adaptations, one of which is angiogenesis. Acutely, exercise leads to release of nitric oxide, prostacyclin (PGI2), and adenosine (A) in the skeletal muscles. In this paper, we asked whether any of these locally released vasodilators, as well as other known dilator prostaglandins (PGE1and PGE2), have the potential to increase angiogenic growth factor gene expression in resting skeletal muscle. Seven groups of 5–7 female Wistar rats (age 8–12 wk, weight 250 ± 10 g) were anesthetized and instrumented for carotid artery pressure and electromagnetic femoral artery blood flow measurement. One group acted as control while the other groups each received one of the following six agents by constant arterial infusion (dose in μg/min): A (200), nitroprusside (NP, 4.2), acetylcholine (100), PGE1(1.9), PGE2(1.7), and PGI2(1.7). Each agent reduced peripheral vascular resistance to a similar extent (at least twofold). Densitometric mRNA/18S levels for vascular endothelial growth factor (VEGF) were increased 50% by NP and acetylcholine, were unaffected by PGE1and PGE2, and were reduced 40% by PGI2. For basic fibroblast growth factor, only PGI2had any effect, reducing mRNA/18S ∼25%. For transforming growth factor-β1, A, NP, and PGE1led to reduced mRNA/18S, whereas PGE2slightly increased mRNA/18S. For the principal putative angiogenic growth factor, VEGF, these data suggest that naturally secreted vasodilators in contracting skeletal muscle could be involved in regulation of gene expression, namely, nitric oxide in a positive and PGI2in a negative direction.